Organization Profile

You just read:

Quest PharmaTech strengthens its Antibody Immunotherapy Technology by licensing anti-MUC1 IgE Technology from Stanford University; Researchers to present late-breaking data at the 28th Annual Meeting of the Society for Immunotherapy of Cancer to be held November 8 - 10, 2013 in Maryland, U.S.

News provided by

Quest PharmaTech Inc.

Nov 07, 2013, 09:30 ET